Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01743625 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain
A Phase 3 study, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 3
- Development phase
- 406
- Enrollment target
NCT01743625 is a Phase 3 study that has completed, run by Mallinckrodt. The registered enrollment target is 406 participants.
The verdict
NCT01743625, a Phase 3 study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 406 participants
- Enrollment target
Study Summary
The purpose of this study is to show the effectiveness of COV155 compared to placebo in subjects with acute moderate to severe pain following bunionectomy surgery.
Interventions
- DRUG placebo
- DRUG COV155
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01743625
The ClinicalTrials.gov registry entry for NCT01743625 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01743625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01743625 about?
NCT01743625 is a clinical study titled "Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain". The purpose of this study is to show the effectiveness of COV155 compared to placebo in subjects with acute moderate to severe pain following bunionectomy surgery.
What is the current status of trial NCT01743625?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 406 participants. The study started on 2012-11. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01743625?
The interventions under investigation include: placebo (DRUG), COV155 (DRUG).
Who is sponsoring clinical trial NCT01743625?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.